{"organizations": [], "uuid": "d3d586c7a3175260de3ac27f24c5b31c0e209a7c", "thread": {"social": {"gplus": {"shares": 0}, "pinterest": {"shares": 0}, "vk": {"shares": 0}, "linkedin": {"shares": 0}, "facebook": {"likes": 0, "shares": 0, "comments": 0}, "stumbledupon": {"shares": 0}}, "site_full": "www.reuters.com", "main_image": "https://s4.reutersmedia.net/resources_v2/images/rcom-default.png", "site_section": "http://www.reuters.com/resources/archive/us/20180123.html", "section_title": "Archive News &amp; Video for Tuesday, 23 Jan 2018 | Reuters.com", "url": "https://www.reuters.com/article/brief-sobi-says-fda-grants-fast-track-st/brief-sobi-says-fda-grants-fast-track-status-for-sobi003-drug-candidate-idUSFWN1PI0F9", "country": "US", "domain_rank": 408, "title": "BRIEF-Sobi says FDA grants fast track status for SOBI003 drug candidate", "performance_score": 0, "site": "reuters.com", "participants_count": 1, "title_full": "", "spam_score": 0.931, "site_type": "news", "published": "2018-01-23T16:06:00.000+02:00", "replies_count": 0, "uuid": "d3d586c7a3175260de3ac27f24c5b31c0e209a7c"}, "author": "Reuters Editorial", "url": "https://www.reuters.com/article/brief-sobi-says-fda-grants-fast-track-st/brief-sobi-says-fda-grants-fast-track-status-for-sobi003-drug-candidate-idUSFWN1PI0F9", "ord_in_thread": 0, "title": "BRIEF-Sobi says FDA grants fast track status for SOBI003 drug candidate", "locations": [], "entities": {"persons": [{"name": "brief-sobi", "sentiment": "negative"}], "locations": [], "organizations": [{"name": "fda", "sentiment": "negative"}, {"name": "reuters", "sentiment": "negative"}, {"name": "eikon", "sentiment": "none"}, {"name": "stockholm newsroom", "sentiment": "none"}]}, "highlightText": "", "language": "english", "persons": [], "text": "Jan 23 (Reuters) - Swedish Orphan Biovitrum:\n* FDA ACCEPTS INVESTIGATIONAL NEW DRUG APPLICATION AND GRANTS FAST TRACK STATUS FOR SOBI003 FOR THE TREATMENT OF MPS IIIA\n* SAYS ‍CLINICAL STUDY WITH SOBI003 IS EXPECTED TO START DURING 2018​ Source text for Eikon: Further company coverage: (Stockholm Newsroom)\n ", "external_links": ["http://thomsonreuters.com/en/about-us/trust-principles.html"], "published": "2018-01-23T16:06:00.000+02:00", "crawled": "2018-01-24T15:47:34.077+02:00", "highlightTitle": ""}